Sustained-release fampridine for multiple sclerosis

JOURNAL ARTICLE published July 2009 in Expert Opinion on Investigational Drugs

Authors: Christopher T Bever | Susan IV Judge

Farnesyl transferase inhibitors in clinical development

JOURNAL ARTICLE published June 2003 in Expert Opinion on Investigational Drugs

Authors: Francesco Caponigro | Marina Casale | Jane Bryce

The therapeutic potential of insulin-mimetic vanadium complexes

JOURNAL ARTICLE published July 2003 in Expert Opinion on Investigational Drugs

Authors: Hiromu Sakurai | Hiroyuki Yasui | Yusuke Adachi

Dasatinib for the treatment of Philadelphia chromosome-positive leukaemias

JOURNAL ARTICLE published May 2007 in Expert Opinion on Investigational Drugs

Authors: Elias Jabbour | Jorge Cortes | Hagop Kantarjian

Cyclophosphamide for scleroderma interstitial lung disease

JOURNAL ARTICLE published March 2007 in Expert Opinion on Investigational Drugs

Authors: Sabina A Antoniu

Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers

JOURNAL ARTICLE published April 2011 in Expert Opinion on Investigational Drugs

Authors: Kevin Smith | Michael Hopp | Gill Mundin | Simon Bond | Paul Bailey | Jo Woodward | Karuppan Palaniappan | Ann Church | Marie Limb | Alyson Connor

Experimental and emerging therapies for chronic hepatitis C virus infection

JOURNAL ARTICLE published August 2001 in Expert Opinion on Investigational Drugs

Authors: Nizar N Zein

Histone deacetylase inhibitors in oral squamous cell carcinoma treatment

JOURNAL ARTICLE published 2 January 2015 in Expert Opinion on Investigational Drugs

Authors: Jason Tasoulas | Constantinos Giaginis | Efstratios Patsouris | Evangelos Manolis | Stamatios Theocharis

JOURNAL ISSUE published July 1996 in Expert Opinion on Investigational Drugs

Monthly Update Cardiovascular & Renal: Sword: Impact on antiarrhythmic drug discovery?

JOURNAL ARTICLE published February 1995 in Expert Opinion on Investigational Drugs

Authors: J Primeau | T Argentieri

Future therapies for rheumatoid arthritis: remedies from the horns of a dilemma?

JOURNAL ARTICLE published July 1997 in Expert Opinion on Investigational Drugs

Authors: Nigel D Staite

Tocolytic therapies in development for preterm labour

JOURNAL ARTICLE published June 1994 in Expert Opinion on Investigational Drugs

Authors: Arthur Wischnik | Wolfgang Zieger

Fertilization promoting peptide (FPP): a new peptide of importance in male fertility?

JOURNAL ARTICLE published June 1994 in Expert Opinion on Investigational Drugs

Authors: Sheena M Cockle

Related articles

JOURNAL ARTICLE published April 2013 in Expert Opinion on Investigational Drugs

JOURNAL ISSUE published February 1999 in Expert Opinion on Investigational Drugs

The status of plasminogen activator inhibitor-1 as a therapeutic target

JOURNAL ARTICLE published May 1997 in Expert Opinion on Investigational Drugs

Authors: Peter Charlton

Do histone deacytelase inhibitors and azacitidine combination hold potential as an effective treatment for high/very-high risk myelodysplastic syndromes?

JOURNAL ARTICLE published 3 June 2021 in Expert Opinion on Investigational Drugs

Authors: Talha Badar | Ehab Atallah

Therapeutic considerations for APOE and TOMM40 in Alzheimers disease: A tribute to Allen Roses MD

JOURNAL ARTICLE published 2 January 2021 in Expert Opinion on Investigational Drugs

Authors: Marwan Noel Sabbagh | Evans Pope | Laura Cordes | Jiong Shi | Boris DeCourt

Paclitaxel poliglumex for ovarian cancer

JOURNAL ARTICLE published June 2011 in Expert Opinion on Investigational Drugs

Authors: Vijaya L Galic | Jason D Wright | Sharyn N Lewin | Thomas J Herzog

Norgestrel may be a potential therapy for retinal degenerations

JOURNAL ARTICLE published May 2012 in Expert Opinion on Investigational Drugs

Authors: Francesca Doonan | Thomas G Cotter